Profit Margin (Quarterly) Chart

View Profit Margin (Quarterly) for OSUR.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Profit Margin (Quarterly) Chart
Start Trial

Historical Profit Margin (Quarterly) Data

View and export this data back to 2000. Start Trial.
Date Value
June 30, 2026 20.40%
March 31, 2026 -80.13%
December 31, 2025 -72.06%
September 30, 2025 -50.63%
June 30, 2025 -63.03%
March 31, 2025 -53.59%
December 31, 2024 -28.83%
September 30, 2024 -11.29%
June 30, 2024 -1.13%
March 31, 2024 -6.62%
December 31, 2023 26.45%
September 30, 2023 12.51%
June 30, 2023 -5.61%
March 31, 2023 17.56%
December 31, 2022 12.84%
September 30, 2022 4.80%
June 30, 2022 -23.17%
March 31, 2022 -29.45%
December 31, 2021 -16.35%
September 30, 2021 -27.85%
June 30, 2021 -2.37%
March 31, 2021 6.44%
December 31, 2020 2.96%
September 30, 2020 2.17%
June 30, 2020 -35.87%
Date Value
March 31, 2020 -23.19%
December 31, 2019 4.91%
September 30, 2019 36.34%
June 30, 2019 11.33%
March 31, 2019 -10.82%
December 31, 2018 20.50%
September 30, 2018 17.64%
June 30, 2018 9.45%
March 31, 2018 -5.05%
December 31, 2017 14.06%
September 30, 2017 13.62%
June 30, 2017 13.51%
March 31, 2017 38.23%
December 31, 2016 20.27%
September 30, 2016 19.35%
June 30, 2016 12.23%
March 31, 2016 8.41%
December 31, 2015 14.25%
September 30, 2015 4.92%
June 30, 2015 6.48%
March 31, 2015 0.42%
December 31, 2014 -9.25%
September 30, 2014 4.09%
June 30, 2014 9.58%
March 31, 2014 -23.92%

Profit Margin Definition

Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.

Read full definition.

Profit Margin (Quarterly) Range, Past 5 Years

View Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Profit Margin (Quarterly) Benchmarks

View Profit Margin (Quarterly) Benchmarks
Start Trial
Abbott Laboratories 7.37%
AngioDynamics, Inc. -13.17%
Alphatec Holdings, Inc. -12.07%
AtriCure, Inc. 5.83%
Baxter International, Inc. 4.56%